News

VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF BIOLOGIC LICENSE APPLICATION OF OMALIZUMAB FOR INJECTION

June 27, 2023


合并PDF_00.jpg

合并PDF_01.jpg




Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat